Calcineurin activity in children with mental handicap

Indian Journal of Clinical Biochemistry

Volumn 22, Issue 2, 2007, Pages 32-35

  Hema Bindu, L ^a   Usha Rani, P ^a   Reddy, P P ^a  

^a OSMANIA UNIVERSITY   (India)

Author keywords

Calcineurin; Calmodulin; CaN inhibitors; Mental handicap; Neurotransmitters

Indexed keywords

CALCINEURIN; CALMODULIN BINDING PROTEIN; NEUROTRANSMITTER;

ADOLESCENT; ARTICLE; BRAIN FUNCTION; CEREBRAL PALSY; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; DISEASE SEVERITY; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; FEMALE; GENE EXPRESSION; HUMAN; INTELLIGENCE QUOTIENT; MALE; MENTAL DEFICIENCY; MENTAL FUNCTION; PATHOPHYSIOLOGY; PROTEIN FUNCTION; PROTEIN SECRETION; PROTEIN SYNTHESIS; PSYCHOMETRY; SIGNAL TRANSDUCTION; SPECIAL EDUCATION;

EID: 36848999992     PISSN: 09701915     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02913309     Document Type: Article

References (22)

1. Wang JH, Desai R. Calcineurin activity. J Biol Chem 1977; 252: 4175-84.
2. Morioka M, Hamada J, Ushio Y, Miyamoto E. Potential role of calcineurin for brain ischemia and traumatic injury. Prog Neurobiol 1999; 58(1): 1-30.
3. Cohen P. The structure and regulation of protein phosphatases. FEBS Lett 1987; 92: 287-93.
4. Fuentes JJ, Genesca L, Kingsbury TJ, Cunnigham KW, Perez-Riba M, Estivill X, de la Luna S. DSCR1, overexpressed in Down syndrome, is an inhibitor of calcineurin mediated signaling pathways. Hum Mol Genet 2000; 9(11): 1681-90.
5. Ermak G, Morgan TE, Davies KJ. Chronic overexpression of the calcineurin inhibitory gene DSCR1 (Adapt 78) is associated with Alzheimer's disease. J Biol Chem 2001; 276(42): 38787-94.
6. Silveira HC, Sommer CA, Soares-Costa A, Henrique-Silva F. A calcineurin inhibitory protein overexpressed in Down's syndrome interacts with the product of a ubiquitously expressed transcript. Braz J Med Biol Res 2004; 37(6): 785-9.
7. Agbas A, Zaidi A, Michaelis EK. Decreased activity and increased aggregation of brain calcineurin during aging. Brain Res 2005; 1059(1): 59-71.
8. Norbert F, James AR, Eric NO. Calsarcins, a novel family of sarcomeric calcineurin binding proteins. Proc Natl Acad 2000; 97(26): 14632-37.
9. Antonio LS, Marta M, Giorgia P, Elisa C, Patrizia C, Terje L, Stefano S. Calcineurin controls nerve activity dependent specification of slow skeletal muscle fibers but not muscle growth. Proc Natl Acad Sci 2001; 98(23): 13108-13.
10. Leslie AL. Caicineurin inhibition and cardiac hypertrophy: A matter of balance. Proc Natl Acad Sci 2001; 98(6): 2947-9.
11. Shibasaki F, Hallin U, Vehino H. Calcineurin as a multifunctional regulator. J Biochem 2002; 131(1): 1-15.
12. Liu F, Grundke-Iqbal I, Iqbal K, Oda Y, Tomizava K, Gong CX. Truncation and activation of calcineurin A by calpain I in Alzheimer's disease brain. J Biol Chem 2005; 280(45): 37755-62.
13. Cook CN, Hejna MJ, Magnuson DJ, Lee JM. Expression of calcipressin 1, an inhibitor of the phosphatase calcineurin, is altered with aging and Alzheimer's disease. J Alzheimers Dis 2005; 8(1): 63-73.
14. Chegounchi M, Hanna MG, Neild GH. Progressive neurological disease induced by tacrolimus in a renal transplant recipient: case presentation. BMC Nephrol 2006; 7: 7.
15. Bechstein WO. Neurotoxicity of calcineurin inhibitors: impact and clinical management. Transpl Int 2000; 13(5): 313-26.
16. Weiguo Z, Jia LL, Masahiro H, Roger J, John MS, George MA, James AR, Thomas CS, Ronald GV. Cyclosporin A induced hypertension involves synapsin in renal sensory nerve endings. Proc Natl Acad 2000; 97(17): 9765-70.
17. German SP, Araceli VL, German SM. Anticonvulsant effect of PKA and calcineurin inhibitors against seizures induced by picrotoxin microdialysis in the rat hippocampus. American Epilepsy Society and American Clinical Neurophysiology Society Joint Annual Meeting 2005.
18. Lakshmikuttyamma A, Selvakumar P, Charavaryamath C, Singh B, Tuchek J, Sharma RK. Expression of calcineurin and its interacting proteins in epileptic fowl. J Neurochem 2006; 96(2): 366-73.
19. Pardo R, Colin E, Regulier E, Aebischer P, Deglon N, Humbert S, Saudou F. Inhibition of calcineurin by FK506 protects against poluglutamine-huntingtin toxicity through an increase of huntingtin phosphorylation at S421. J Neurosci 2006; 26(5): 1635-45.
20. Hernandez-Espinosa D, Morton AJ. Calcineurin inhibitors cause an acceleration of neurological phenotype in a mouse transgenic for the human Huntington's disease mutation. Brain Res Bull 2006: 69(6): 669-79.
21. Vemartomari I, Tabuchi K, Hoshino T, Hara A. Protective effect of calcineurin inhibitors on acoustic injury of the cochlea. Hear. Res. 2005: 209(1-2): 86-90.
22. Mobley LW3rd, Agrawal SK. Role of calcineurin in calcium-mediated hypoxic injury to white matter. Spine J 2003; 3(1): 11-8.